Login / Signup
Another disappointment in treating relapsed, refractory high-risk aggressive B-cell lymphomas.
Toby Andrew Eyre
Published in:
British journal of haematology (2019)
Keyphrases
</>
acute lymphoblastic leukemia
acute myeloid leukemia
multiple myeloma
hodgkin lymphoma
diffuse large b cell lymphoma